As per the NKA World report, “The WHO announced on Thursday the interim results of a clinical trial which is coordinated that show Remdesivir appears to have little or no effect in preventing death from COVID-19 or reducing time in hospital. The trial was carried out in more than 400 hospitals in 30 countries.”
In a news conference, WHO Director-General Tedros Adhanom Ghebreyesus said that he expects the full results to be published shortly.
According to Chief Scientist of WHO Soumya Swaminathan said she thinks regulatory agencies of countries will reanalyze the trial data and decide whether emergency use should be recommended.
As of now, the WHO said that the steroid Dexamethasone, used to treat pneumonia, is the only drug effective for people seriously-ill with COVID-19, NHK World said.